Cardiac effects of tiotropium bromide in patients with chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 213s Year: 2006
Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005
Efficacy and safety of salmeterol in patients with bronchial asthma (BA) and ischemic heart disease (IHD) Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002
Underestimation of bronchial obstruction in patients with coronary heart disease and cardiac insufficiency Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
The study of the damage degree of myocardial coronary blood flow in patients with chronic obstructive pulmonary disease and severe bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Effects of cardiovascular agents on respiratory function in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006
Underappreciation of coronary artery disease in patients with COPD Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020
Lung diffusion capacity is reduced in patients with coronary artery disease and no signs of heart failure Source: Eur Respir J 2006; 28: Suppl. 50, 406s Year: 2006
Pulmonary artery hypertension and severity of airflow limitation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006
Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Angiographically objectified presence of coronary artery disease in patients with exacerbated chronic obstructive pulmonary disease and raised troponin I - The BEETHOVEN trial Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD) Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001
Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Blood pressure and heart rate variability response to noninvasive ventilation in patients with exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007
Reduced heart rate variability in chronic bronchial asthma with steroid dependency Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)> Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020
Impact of COPD in patients with coronary heart disease submitted to coronary heart bypass graft Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014